JP2004515550A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004515550A5 JP2004515550A5 JP2002549679A JP2002549679A JP2004515550A5 JP 2004515550 A5 JP2004515550 A5 JP 2004515550A5 JP 2002549679 A JP2002549679 A JP 2002549679A JP 2002549679 A JP2002549679 A JP 2002549679A JP 2004515550 A5 JP2004515550 A5 JP 2004515550A5
- Authority
- JP
- Japan
- Prior art keywords
- fluorophenyl
- pyrazolo
- pyridine
- amine
- pyrimidinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 126
- 125000006312 cyclopentyl amino group Chemical group [H]N(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 40
- -1 2-Amino-4-pyrimidinyl Chemical group 0.000 claims description 35
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 29
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 22
- 125000006309 butyl amino group Chemical group 0.000 claims description 19
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 10
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 8
- 125000001475 halogen functional group Chemical group 0.000 claims description 8
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 150000003973 alkyl amines Chemical class 0.000 claims description 6
- 150000005215 alkyl ethers Chemical class 0.000 claims description 6
- 125000005189 alkyl hydroxy group Chemical group 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000005157 alkyl carboxy group Chemical group 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 4
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000012453 solvate Substances 0.000 claims description 4
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 3
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims description 2
- TVWMHJOLEDVFFP-UHFFFAOYSA-N 2-(4-fluorophenyl)-3,7-bis(2-fluoropyridin-4-yl)pyrazolo[1,5-a]pyridine Chemical compound C1=CC(F)=CC=C1C1=NN(C(=CC=C2)C=3C=C(F)N=CC=3)C2=C1C1=CC=NC(F)=C1 TVWMHJOLEDVFFP-UHFFFAOYSA-N 0.000 claims description 2
- QDZOJLCCONWJLX-UHFFFAOYSA-N 2-(4-fluorophenyl)-7-iodo-3-pyridin-4-ylpyrazolo[1,5-a]pyridine Chemical compound C1=CC(F)=CC=C1C1=NN(C(I)=CC=C2)C2=C1C1=CC=NC=C1 QDZOJLCCONWJLX-UHFFFAOYSA-N 0.000 claims description 2
- PPLLZTCPKKKXMG-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[2-(1-methylpyrrolidin-2-yl)ethyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyridin-7-amine Chemical compound CN1CCCC1CCNC1=CC=CC2=C(C=3C=CN=CC=3)C(C=3C=CC(F)=CC=3)=NN12 PPLLZTCPKKKXMG-UHFFFAOYSA-N 0.000 claims description 2
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 claims description 2
- 125000006325 2-propenyl amino group Chemical group [H]C([H])=C([H])C([H])([H])N([H])* 0.000 claims description 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 claims description 2
- PYLRHIDDAWYMMF-UHFFFAOYSA-N 4-[7-chloro-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentyl-5-methylpyrimidin-2-amine Chemical compound N1=C(C2=C3C=CC=C(Cl)N3N=C2C=2C=CC(F)=CC=2)C(C)=CN=C1NC1CCCC1 PYLRHIDDAWYMMF-UHFFFAOYSA-N 0.000 claims description 2
- QVRZLKHJUGMNMS-UHFFFAOYSA-N 4-[7-chloro-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentyl-6-[(dimethylamino)methyl]pyrimidin-2-amine Chemical compound N=1C(CN(C)C)=CC(C2=C3C=CC=C(Cl)N3N=C2C=2C=CC(F)=CC=2)=NC=1NC1CCCC1 QVRZLKHJUGMNMS-UHFFFAOYSA-N 0.000 claims description 2
- ASGXYPABAFMGKT-UHFFFAOYSA-N 4-[7-chloro-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentyl-6-methylpyrimidin-2-amine Chemical compound N=1C(C)=CC(C2=C3C=CC=C(Cl)N3N=C2C=2C=CC(F)=CC=2)=NC=1NC1CCCC1 ASGXYPABAFMGKT-UHFFFAOYSA-N 0.000 claims description 2
- CCEYYRWZLBJDHK-UHFFFAOYSA-N 4-[7-chloro-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentylpyrimidin-2-amine Chemical compound C1=CC(F)=CC=C1C1=NN(C(Cl)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 CCEYYRWZLBJDHK-UHFFFAOYSA-N 0.000 claims description 2
- WNWVKZTYMQWFHE-UHFFFAOYSA-N 4-ethylmorpholine Chemical group [CH2]CN1CCOCC1 WNWVKZTYMQWFHE-UHFFFAOYSA-N 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims description 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 2
- UMBKZMBLMSTZKH-UHFFFAOYSA-N 6-[7-chloro-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(cyclopentylamino)pyrimidine-4-carboxylic acid Chemical compound N=1C(C(=O)O)=CC(C2=C3C=CC=C(Cl)N3N=C2C=2C=CC(F)=CC=2)=NC=1NC1CCCC1 UMBKZMBLMSTZKH-UHFFFAOYSA-N 0.000 claims description 2
- LRSNFQBSTKTYKI-UHFFFAOYSA-N 6-[7-chloro-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentyl-2-(cyclopentylamino)pyrimidine-4-carboxamide Chemical compound C1=CC(F)=CC=C1C1=NN(C(Cl)=CC=C2)C2=C1C1=CC(C(=O)NC2CCCC2)=NC(NC2CCCC2)=N1 LRSNFQBSTKTYKI-UHFFFAOYSA-N 0.000 claims description 2
- MKMQOVQANWMIIT-UHFFFAOYSA-N 7-bromo-2-(4-fluorophenyl)-3-pyridin-4-ylpyrazolo[1,5-a]pyridine Chemical compound C1=CC(F)=CC=C1C1=NN(C(Br)=CC=C2)C2=C1C1=CC=NC=C1 MKMQOVQANWMIIT-UHFFFAOYSA-N 0.000 claims description 2
- VKZZXFMSDDDGAV-UHFFFAOYSA-N 7-chloro-2-(4-fluorophenyl)-3-(2-phenylpyrimidin-4-yl)pyrazolo[1,5-a]pyridine Chemical compound C1=CC(F)=CC=C1C1=NN(C(Cl)=CC=C2)C2=C1C1=CC=NC(C=2C=CC=CC=2)=N1 VKZZXFMSDDDGAV-UHFFFAOYSA-N 0.000 claims description 2
- 208000029433 Herpesviridae infectious disease Diseases 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- GYPRSMQRMSLJFX-UHFFFAOYSA-N [6-[7-chloro-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(cyclopentylamino)pyrimidin-4-yl]methanol Chemical compound N=1C(CO)=CC(C2=C3C=CC=C(Cl)N3N=C2C=2C=CC(F)=CC=2)=NC=1NC1CCCC1 GYPRSMQRMSLJFX-UHFFFAOYSA-N 0.000 claims description 2
- 125000005431 alkyl carboxamide group Chemical group 0.000 claims description 2
- 125000004422 alkyl sulphonamide group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000006317 cyclopropyl amino group Chemical group 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 2
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 claims description 2
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 claims description 2
- XXUMHEXVTRQQTL-UHFFFAOYSA-N n-butyl-4-[2-(4-fluorophenyl)-7-(furan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(N3N=C2C=2C=CC(F)=CC=2)C=2OC=CC=2)=N1 XXUMHEXVTRQQTL-UHFFFAOYSA-N 0.000 claims description 2
- GUDXKTGWOFKDLD-UHFFFAOYSA-N n-cyclopentyl-4-[2-(4-fluorophenyl)-7-hydrazinylpyrazolo[1,5-a]pyridin-3-yl]-6-methylpyrimidin-2-amine Chemical compound N=1C(C)=CC(C2=C3C=CC=C(NN)N3N=C2C=2C=CC(F)=CC=2)=NC=1NC1CCCC1 GUDXKTGWOFKDLD-UHFFFAOYSA-N 0.000 claims description 2
- SOWBFZRMHSNYGE-UHFFFAOYSA-N oxamic acid Chemical compound NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
- 238000011321 prophylaxis Methods 0.000 claims description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims description 2
- OYRRZWATULMEPF-UHFFFAOYSA-N pyrimidin-4-amine Chemical compound NC1=CC=NC=N1 OYRRZWATULMEPF-UHFFFAOYSA-N 0.000 claims description 2
- HKSQZEGSMBFHGC-UHFFFAOYSA-N pyrimidine-4-carboxamide Chemical compound NC(=O)C1=CC=NC=N1 HKSQZEGSMBFHGC-UHFFFAOYSA-N 0.000 claims description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 2
- 238000011282 treatment Methods 0.000 claims description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 125000000586 2-(4-morpholinyl)ethoxy group Chemical group [H]C([H])(O*)C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims 1
- MTUPINQDZNXFAG-UHFFFAOYSA-N 2-[[3-[2-(cyclopentylamino)-6-methylpyrimidin-4-yl]-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]acetic acid Chemical compound N=1C(C)=CC(C2=C3C=CC=C(NCC(O)=O)N3N=C2C=2C=CC(F)=CC=2)=NC=1NC1CCCC1 MTUPINQDZNXFAG-UHFFFAOYSA-N 0.000 claims 1
- AGHBQALSJZKTMH-UHFFFAOYSA-N 3-[[4-[7-(butylamino)-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-yl]amino]propan-1-ol Chemical compound N=1N2C(NCCCC)=CC=CC2=C(C=2N=C(NCCCO)N=CC=2)C=1C1=CC=C(F)C=C1 AGHBQALSJZKTMH-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- HDOVUKNUBWVHOX-QMMMGPOBSA-N Valacyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 HDOVUKNUBWVHOX-QMMMGPOBSA-N 0.000 claims 1
- NMGBNZIPZPBKAJ-UHFFFAOYSA-N [2-(cyclopentylamino)-6-[7-(cyclopentylamino)-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]pyrimidin-4-yl]methanol Chemical compound N=1C(CO)=CC(C2=C3C=CC=C(NC4CCCC4)N3N=C2C=2C=CC(F)=CC=2)=NC=1NC1CCCC1 NMGBNZIPZPBKAJ-UHFFFAOYSA-N 0.000 claims 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims 1
- 229960004150 aciclovir Drugs 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- PVUFXIOCHVKIMH-UHFFFAOYSA-N methyl 2-[[3-[2-(cyclopentylamino)-6-methylpyrimidin-4-yl]-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]acetate Chemical compound N=1N2C(NCC(=O)OC)=CC=CC2=C(C=2N=C(NC3CCCC3)N=C(C)C=2)C=1C1=CC=C(F)C=C1 PVUFXIOCHVKIMH-UHFFFAOYSA-N 0.000 claims 1
- 239000001294 propane Substances 0.000 claims 1
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Natural products NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 claims 1
- 229940093257 valacyclovir Drugs 0.000 claims 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 229960002449 glycine Drugs 0.000 description 2
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N 1-propanol Substances CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- DBVSTACDKGPBFJ-UHFFFAOYSA-N 1-pyridin-2-ylpropane-1,3-diamine Chemical compound NCCC(N)C1=CC=CC=N1 DBVSTACDKGPBFJ-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25576300P | 2000-12-15 | 2000-12-15 | |
| US27428401P | 2001-03-08 | 2001-03-08 | |
| PCT/US2001/044231 WO2002048148A2 (en) | 2000-12-15 | 2001-11-26 | Pyrazolopyridine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004515550A JP2004515550A (ja) | 2004-05-27 |
| JP2004515550A5 true JP2004515550A5 (https=) | 2005-12-22 |
Family
ID=26944940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002549679A Ceased JP2004515550A (ja) | 2000-12-15 | 2001-11-26 | 治療用化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7163940B2 (https=) |
| EP (1) | EP1377573B1 (https=) |
| JP (1) | JP2004515550A (https=) |
| AT (1) | ATE300541T1 (https=) |
| AU (1) | AU2002239348A1 (https=) |
| DE (1) | DE60112330T2 (https=) |
| ES (1) | ES2243579T3 (https=) |
| WO (1) | WO2002048148A2 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
| JP2004515550A (ja) | 2000-12-15 | 2004-05-27 | グラクソ グループ リミテッド | 治療用化合物 |
| ATE301653T1 (de) | 2000-12-15 | 2005-08-15 | Glaxo Group Ltd | Pyrazolopyridine |
| WO2002072581A2 (en) | 2001-03-08 | 2002-09-19 | Smithkline Beecham Corporation | Pyrazolopyriadine derivatives |
| WO2002078701A1 (en) * | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Use of pyrazolopyridines as therapeutic compounds |
| WO2002078700A1 (en) | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Pyralopyridines, process for their preparation and use as therapteutic compounds |
| ES2266487T3 (es) | 2001-04-10 | 2007-03-01 | Smithkline Beecham Corporation | Compuestos de pirazolopirina antivirales. |
| ATE296826T1 (de) | 2001-04-27 | 2005-06-15 | Smithkline Beecham Corp | Pyrazolo(1,5)pyridinderivate |
| ATE337316T1 (de) | 2001-06-21 | 2006-09-15 | Smithkline Beecham Corp | Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen |
| US7115617B2 (en) | 2001-08-22 | 2006-10-03 | Amgen Inc. | Amino-substituted pyrimidinyl derivatives and methods of use |
| US6939874B2 (en) | 2001-08-22 | 2005-09-06 | Amgen Inc. | Substituted pyrimidinyl derivatives and methods of use |
| US20040214834A1 (en) * | 2001-09-07 | 2004-10-28 | Kristjan Gudmunsson | Pyrazolo-pyridines for the treatment of herpes infections |
| EP1432712B1 (en) | 2001-10-05 | 2006-05-17 | SmithKline Beecham Corporation | Imidazo-pyridine derivatives for use in the treatment of herpes viral infection |
| JP2005516916A (ja) | 2001-12-11 | 2005-06-09 | スミスクライン ビーチャム コーポレーション | 抗ヘルペス薬としてのピラゾロ−ピリジン誘導体 |
| DE60301339T2 (de) | 2002-03-07 | 2006-03-09 | Smithkline Beecham Corp. | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen |
| JP2006504728A (ja) * | 2002-10-03 | 2006-02-09 | スミスクライン ビーチャム コーポレーション | ピラソロピリジン誘導体系治療用化合物 |
| EP1644338A1 (en) * | 2003-04-01 | 2006-04-12 | Aponetics AG | 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases |
| WO2006055245A2 (en) * | 2004-11-17 | 2006-05-26 | Smithkline Beecham Corporation | Process for preparing pyrazolopyridine compounds |
| EP1891018B1 (en) * | 2005-05-24 | 2011-11-16 | Vertex Pharmaceuticals, Inc. | Modulators of atp-binding cassette transporters |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| WO2011103441A1 (en) | 2010-02-18 | 2011-08-25 | Schering Corporation | Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| EP2402336A1 (en) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds |
| EP2402335A1 (en) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds |
| JP6211522B2 (ja) * | 2011-10-06 | 2017-10-11 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | ヘテロシクリルピリ（ミ）ジニルピラゾール |
| NZ746607A (en) | 2012-11-21 | 2019-11-29 | Ptc Therapeutics Inc | Substituted reverse pyrimidine bmi-1 inhibitors |
| EP3836932A2 (en) | 2018-08-17 | 2021-06-23 | PTC Therapeutics, Inc. | Method for treating pancreatic cancer |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US46478A (en) * | 1865-02-21 | Isaac s | ||
| US3666440A (en) * | 1970-03-13 | 1972-05-30 | Mitsubishi Metal Mining Co Ltd | Method of recovering copper from slag |
| EP0151962A3 (en) * | 1984-01-25 | 1985-10-02 | Beecham Group Plc | Pyrazolopyridine derivatives |
| GB8404586D0 (en) * | 1984-02-22 | 1984-03-28 | Beecham Group Plc | Compounds |
| GB8404584D0 (en) * | 1984-02-22 | 1984-03-28 | Beecham Group Plc | Compounds |
| US5002941A (en) | 1985-12-12 | 1991-03-26 | Smithkline Beecham Corporation | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
| US4925849A (en) * | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
| US5155114A (en) * | 1989-01-23 | 1992-10-13 | Fujisawa Pharmaceutical Company, Ltd. | Method of treatment using pyrazolopyridine compound |
| GB8901423D0 (en) | 1989-01-23 | 1989-03-15 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
| JPH05503919A (ja) | 1989-06-13 | 1993-06-24 | スミスクライン・ビーチャム・コーポレイション | 単球および／またはマクロファージによるインターロイキン―１または腫瘍壊死因子生成の抑制 |
| AU622330B2 (en) * | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
| AU8205991A (en) | 1990-06-12 | 1992-01-07 | Smithkline Beecham Corporation | Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases |
| GB9015764D0 (en) * | 1990-07-18 | 1990-09-05 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
| DE69232323T2 (de) | 1991-01-29 | 2002-08-08 | Fujisawa Pharmaceutical Co., Ltd. | Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera |
| GB9107513D0 (en) * | 1991-04-10 | 1991-05-29 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
| US5300478A (en) * | 1993-01-28 | 1994-04-05 | Zeneca Limited | Substituted fused pyrazolo compounds |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5521213A (en) | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| US5552422A (en) * | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| CN1186492A (zh) | 1995-04-04 | 1998-07-01 | 葛兰素集团有限公司 | 咪唑并[1,2－α]吡啶衍生物 |
| US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
| EP0833664A1 (en) | 1995-06-12 | 1998-04-08 | G.D. SEARLE & CO. | Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| ES2247604T3 (es) | 1995-06-12 | 2006-03-01 | G.D. SEARLE & CO. | Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa. |
| FR2757059B1 (fr) | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouvelle application therapeutique des derives du pyrrole |
| FR2757166B1 (fr) * | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
| AU7966198A (en) | 1997-06-13 | 1998-12-30 | Smithkline Beecham Corporation | Novel pyrazole and pyrazoline substituted compounds |
| DK1032575T3 (da) | 1997-09-05 | 2003-10-20 | Glaxo Group Ltd | 2,3-diaryl-pyrazol(1,5-b)pyridazinderivater, deres fremstilling og anvendelse som cyclooxygenase 2 (COX-2) inhibitor |
| EP1077971A1 (en) | 1998-05-14 | 2001-02-28 | G.D. SEARLE & CO. | 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
| FR2779724B1 (fr) | 1998-06-10 | 2001-04-20 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US7223772B1 (en) | 1998-11-03 | 2007-05-29 | Smithkline Beecham Corporation | Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| ATE261444T1 (de) | 1999-02-27 | 2004-03-15 | Glaxo Group Ltd | Pyrazolopyridine |
| ES2215670T3 (es) | 1999-06-28 | 2004-10-16 | Janssen Pharmaceutica N.V. | Inhibidores de la replicacion del virus sincitial respiratorio. |
| GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
| PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
| AUPQ969800A0 (en) | 2000-08-28 | 2000-09-21 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
| ATE301653T1 (de) | 2000-12-15 | 2005-08-15 | Glaxo Group Ltd | Pyrazolopyridine |
| JP2004515550A (ja) | 2000-12-15 | 2004-05-27 | グラクソ グループ リミテッド | 治療用化合物 |
| GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
| WO2002078701A1 (en) * | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Use of pyrazolopyridines as therapeutic compounds |
| ATE296826T1 (de) * | 2001-04-27 | 2005-06-15 | Smithkline Beecham Corp | Pyrazolo(1,5)pyridinderivate |
| WO2003000682A1 (en) | 2001-06-25 | 2003-01-03 | Merck & Co., Inc. | (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| US7278211B2 (en) * | 2002-12-12 | 2007-10-09 | Shell Oil Company | Bore hole tool assembly and method of designing same |
-
2001
- 2001-11-26 JP JP2002549679A patent/JP2004515550A/ja not_active Ceased
- 2001-11-26 AU AU2002239348A patent/AU2002239348A1/en not_active Abandoned
- 2001-11-26 WO PCT/US2001/044231 patent/WO2002048148A2/en not_active Ceased
- 2001-11-26 EP EP01987099A patent/EP1377573B1/en not_active Expired - Lifetime
- 2001-11-26 AT AT01987099T patent/ATE300541T1/de not_active IP Right Cessation
- 2001-11-26 DE DE60112330T patent/DE60112330T2/de not_active Expired - Fee Related
- 2001-11-26 ES ES01987099T patent/ES2243579T3/es not_active Expired - Lifetime
- 2001-11-26 US US10/433,881 patent/US7163940B2/en not_active Expired - Fee Related
-
2006
- 2006-10-04 US US11/538,462 patent/US20070287721A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004515550A5 (https=) | ||
| JP2004525149A5 (https=) | ||
| JP2004527560A5 (https=) | ||
| RU2412943C2 (ru) | ПРОИЗВОДНЫЕ АЦЕТИЛЕНИЛ-ПИРАЗОЛО-ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR2 | |
| RU2386630C2 (ru) | Соединения и композиции в качестве ингибиторов протеинтирозинкиназы | |
| AU778450B2 (en) | Fused imidazole compounds and remedies for diabetes mellitus | |
| JP2007520540A5 (https=) | ||
| TWI629266B (zh) | 纖維母細胞生長因子受體之抑制劑 | |
| JP2022184886A5 (https=) | ||
| JP2004518651A5 (https=) | ||
| JP2005500315A5 (https=) | ||
| JP2011510995A5 (https=) | ||
| RU97110269A (ru) | 6-арилпиридо-[2,3-d]-пиримидины и -нафтиридины, предназначенные для ингибирования клеточной пролиферации, опосредованной протеин-тирозин-киназой | |
| JP2003535828A5 (https=) | ||
| JP2004529926A5 (https=) | ||
| KR20190046921A (ko) | 세포 대사 과정의 억제제 | |
| RU2021129721A (ru) | Пирролопиримидины в качестве потенциаторов мвтр | |
| SI2925757T1 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| RU2006109474A (ru) | Замещенные 8-гетероарилксантины | |
| JP2016505529A5 (https=) | ||
| RU2008107264A (ru) | Производные пиразина, полезные в качестве антагонистов аденозинового рецептора | |
| ME01282B (me) | Jedinjenja pirolopirimidina kao inhibitori cdk | |
| CA2644841C (en) | Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia | |
| JP2008511669A5 (https=) | ||
| HRP20121022T1 (hr) | Kondenzirani bicikliäśki pirimidini |